Table 2 Pattern of recurrence

From: Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

     

P -values

 

Total ( N =72)

NMA ( N =58)

AIM ( N =4)

MAC ( N =10)

AIM vs NMA

MAC vs NMA

AIM vs MAC

Pattern of recurrence a

Local recurrence

10 (13.9%)

8 (13.8%)

1 (25.0%)

1 (10.0%)

0.48

1.00

0.505

Distant metastasis

62 (86.1%)

50 (86.2%)

3 (75.0%)

9 (90.0%)

   

Initial site involved in case of distant metastasis b

Lung

25 (40.3%)

22 (44.0%)

1 (33.3%)

2 (22.2%)

1.00

0.29

1.00

Liver

19 (30.6%)

17 (34.0%)

0 (0%)

2 (22.2%)

0.54

0.70

1.00

Lymph node

19 (30.6%)

17 (34.0%)

2 (66.7%)

0 (0%)

0.29

0.048

0.045

Peritoneum

20 (32.3%)

13 (26.0%)

2 (66.7%)

5 (55.6%)

0.19

0.12

1.00

Bone

2 (3.2%)

2 (4.0%)

0 (0%)

0 (0%)

1.00

1.00

—

  1. Abbreviations: AIM=adenocarcinoma with intermediate mucinous component; MAC=mucinous adenocarcinoma; NMA=non-mucinous adenocarcinoma.
  2. Analysis among patients with recurrence.
  3. Analysis among patients having distal metastasis.
Back to article page